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 Background and Objectives:  Epigenetic mechanisms have been associated with gene 
regulation contributing with inflammatory pathway activation in periodontal disease. It has been 
shown that pathogenic bacteria are capable of dysregulating the epigenetic machinery of their 
target cells. Considering gingival epithelial cells function as the forefront defense line of 
periodontal tissues against microbial invasions, in this study we aimed to investigate the potential 
effects of antioxidant resveratrol as DNA methyltransferase (DNMT) inhibitor in comparison to 
epi-gallocatechin-3-gallate (EGCG) on epithelial barrier function in response to Porphyromonas 
gingivalis infection of human gingival epithelial cells. 
 Material and Methods: Primary human gingival epithelial cells (HGEp) were used and 
maintained following manufacturer’s instructions. PrestoBlue® Cell Viability Assay was used to 
analyze the cytotoxicity of resveratrol and determine an optimum inhibitor concentration. Primary 
human gingival epithelial cells were induced with P.gingivalis, strain A7436 (MOI 50), in presence 
or absence of EGCG and resveratrol. Transepithelial electrical resistance (TEER) was recorded 
using an EVOM® electrical resistance system at various time points. In addition, DNA methylation 
and mRNA expression levels were quantified by qPCR using EpiTect Methyl II PCR and TaqMan 
PCR Assays for TJP1. 
 Results: In comparison to infected controls, exposure of HGEp cells to P. gingivalis 
decreased TEER (p<0.05) levels in association with increased cell permeability. Also, DNA 
 
iv 
methylation assays showed increased methylation levels of the junctional protein TJP-1 using non-
infected cells as controls (p<0.05). Transcriptome analysis of TJP-1 showed down-regulation 
(p<0.05) of these genes of adhesion function. For infected cells pre-treated by resveratrol and 
EGCG, the methylation levels of TJP-1 were reduced and associated mRNA expression increased 
significantly (p<0.05) compared to infected cells.  
 Conclusion: The DNMT inhibitor resveratrol could prevent hypermethylation measured at 
the promoter regions of TJP-1 in epithelial cells exposed to P. gingivalis infection, similarly to 
EGCG. Epigenetic regulation can affect epithelial barrier function, another important factor in the 
initiation and progression of periodontal diseases. 
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CHAPTER 1: Literature Review 
1.1 Epigenetics & DNA Methylation – An Overview 
 Epigenetics is a rapidly evolving field we are constantly gaining more knowledge of in 
regards to environmental effects on genetic changes. The classical definition of epigenetics is a 
stably heritable trait resulting from changes in a chromosome without alterations in the DNA 
sequence [proposed by Conrad Waddington in the 1950s]. Waddington coined the term derived 
from Greek root word ‘epigenesis,’ which explores both embryology’s and genetics’ influence in 
the gradual development of organs and tissues from molecular instruction. Unlike mutations, 
epigenetic effects can be reversed and therefore are considered to be transient changes. The 
environment provides a heavy source of epigenetic influence on gene function. These 
environmental factors include, but are not limited to, smoking, diet, stress, and infection (Barros 
S.P. & Offenbacher S., 2009). The phenotype that results in the offspring is passed via mitosis 
and/or meiosis, but other proposed mechanisms are involved in the initiation and maintenance of 
the epigenetic traits. Epigenetic modifications consist of a series of chemical alterations of DNA 
and proteins which lead to the remodeling of chromatin as well as the activation or inactivation 
of specific genes (Ari G et al., 2016). These epigenetic mechanisms consist of DNA methylation, 
histone modification, and gene regulation by non-coding RNAs. These mechanisms occur from 
chemical alterations known as phosphorylation, acetylation, and ubiquitinylation. In 1975, 
Holliday & Pugh published an article suggesting enzymatic methylation of cytosine residues in 
DNA as a model for gene heritability (Holliday and Pugh 1975; Riggs AD, 1975). These authors 
discussed the concept of methylation as being a driving factor in the switching ‘on and off’ of 
 
2 
gene activity during development, as well as the possible heritability of these methylation 
patterns to offspring. Traditionally we have learned the heritability of traits is through the Central 
Dogma (DNA-RNA-Protein), but epigenetics offers a new perspective on how some genes can 
be silenced or expressed. Epigenetics has challenged the traditional view and broadened the 
possibility of new phenotype expression as well as inactivation.  Unlike the classic heritability 
model, epigenetics suggests there is a constant source of gene modifications which can 
accumulate throughout an organism’s life.  
 The methylation of cytosine residues in mammalian DNA is one of the most studied and 
understood epigenetic modifications (Bird A., 2002). DNA Methylation is considered a covalent 
bond which occurs at the cytosine base of a 5’ guanosine residue. In the genome there are 
regions rich in these sequences, known as ‘CpG islands’, where repeated cytosine and guanosine 
nucleotides link to their complementary strand via a phosphate (the “p” in CpG). These CpG-rich 
islands represent areas highly associated with the methylation process and can extend up to 3000 
base pairs (Janitz, K., & Janitz, M. 2011). These CpG dinucleotide-rich regions tend to occur on 
the promoter regions and first exons of housekeeping genes (Larsen et. al., 1992). Housekeeping 
genes are associated with maintaining basic cell function and survival. Unlike other tissue-
specific genes, these genes are highly conserved and evolve more slowly due to their essence in 
maintaining normal cell function (Zhang and Li, 2004).  
 The enzymes involved in DNA methylation are known as DNA methyltransferases 
(DNMT’s) and they work by inserting a methyl group and maintaining the induced methylation 
patterns.  Three active isoforms of this enzyme exist known as DNMT-1, DNMT-3A and 3B, 
and DNMT-3L. The DNMT-1 enzyme is primarily responsible for inducing and maintaining 
methylation. The DNMT-1 enzyme facilitates the donation of a methyl group to the C5 in the 
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cytosine of a CpG pair. The addition of this group leads to an alteration that skews the natural 
formation of the major groove. This new group disturbs the natural double helix formation of the 
DNA and inhibits binding and function of normal transcription factors involved in converting 
DNA to RNA. Consequently, these methylated regions are unable to be transcribed and 
translated into protein (Yin L., et al., 2011). Instead, the exposed methyl groups attract methyl-
binding proteins which leads to histone modification, compacting chromatin and silencing the 
genes in the region (Bird and Wolffe, 1999).  Ultimately, the presence of methylation will 
usually result in gene silencing (Tang M, et al., 2009).   
 Figure 1.1.1 illustrates how epigenetics influences proteins by affecting the transcription 
and translation processes of DNA (Barros, S.P., et al., 2020).  The methyl groups bind to the 
cytosine residues thus altering the DNA structure and leading to changes in protein expression. 
The figure also illustrates an additional epigenetic alteration mechanism, histone deacetylation. 
During replication, lysine residues at the amino terminus are acetylated which relax the 
conformation of the chromatin allowing for enhanced gene transcription. Histone deacetylation, 
in contrast, prevents the ability of the chromatin to relax which in turn prevents binding of 
transcription factors, repressing transcription. The impact of these modifications is still being 
investigated in the role of periodontal disease, but the processes of histone 
acetylation/deacetylation have been connected to preventing alveolar bone loss and the 




Figure 1.1.1: Epigenetic modifications of methylation and histone deacetylation. In the presence 
of methylation and deacetylation, gene translation is inhibited and gene expression is turned 
‘off.’ DNA methylation usually occurs at the cytosine nucleotides of CpG-rich regions. In 
contrast, unmethylated regions of DNA and acetylated histone tails are able to be transcribed and 
translated and gene expression is turned ‘on.’ 
 
1.2 Epigenetic Mechanisms 
 Two major mechanisms exist which contribute to epigenetics: methylation and histone 
modification. Methylation mainly occurs at cytosine residues of 5’-Cytosine-phospho-
Guanosine-3’ (CpG)-rich islands. The methylation of these sites is maintained by DNA-
methyltransferases (DNMT’s). The methylation of these sites inhibit binding of transcriptional 
factors which inhibits translation and consequently leads to gene silencing.  To summarize 
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simply, hypermethylation usually leads to silencing of genes and hypomethylation usually results 
in overexpression of genes. Gene silencing can serve as a protective factor because 
overexpression of genes can result in tumorigenesis (Egger G, et al., 2004). However, if tumor-
suppressor genes are the ones being silenced then there is also the risk of tumorigenesis. In 
regards to periodontitis, preliminary evidence exists to show hypomethylation of genes encoding 
inflammatory marker interleukin-6 (IL-6) leads to increased activity of its role in inflammation 
(Offenbacher S, Barros SP, 2007). Hypomethylation of the genes specific to this inflammatory 
marker, therefore, will increase its expression and result in increased inflammatory activity.  
 Martin E.M. & Fry R.C (2018) discuss how the environment and epigenetics affect gene 
expression through what is known as the ‘transcription factor occupancy theory.’ This theory 
helps explain the role of environmental factors on methylation enzymes. According to the 
transcription factor occupancy theory, the environment will alter and affect the binding of 
transcription factors to DNA. The presence of an environmental contaminant, such as smoking, 
diet, etc., can inhibit the binding of transcription factors to DNA. When the transcription factors 
are unable to bind to DNA, the DNMT’s then have access to these specific sites and are able to 
insert methyl groups. Transcription and translation of these specific methylated regions is then 
inhibited, thus leading to silencing of the genes specific to that region. 
 Epigenetics also alter gene expression with histone protein modification. Histone 
deacetylase enzymes can interact with the histone and change the chromatin structure. This 
mechanism works via acetylation of lysine residues of histones which activate gene expression 
and upregulate physiologic activity. Although these epigenetic modifications can be influenced 
externally by the individual’s environment, they can also be transferred to offspring. This theory 
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suggests that modifications from previous generations can influence gene activity on later 
generations.  
1.3 Epigenetics & Periodontitis 
 Periodontitis is characterized as a disease of chronic inflammation of the periodontal 
tissues in response to bacteria. The presence of chronic inflammation leads to the breakdown of 
vital tooth-supporting tissues, the periodontal ligament and alveolar bone. Host cells recognize 
periodontal bacteria and initiate the innate immune response which later progresses into the 
adaptive response via B and T lymphocytes.  
 A key component of periodontitis is host response, which accounts for the variety in 
disease expression amongst individuals (Kornman KS., 2008). Risk factors for periodontal 
disease are multifactorial and include bacteria, smoking, diet, as well as genetics and epigenetics 
(Offenbacher S, Barros SP, Beck JD., 2008). Evidence suggests that specific polymorphisms are 
associated with periodontal disease and can influence the immune response (Yoshie H., et. al., 
2007). Increasing the complexity of the disease etiology and host response mechanisms are the 
gene-environmental interactions which are continuously showing more significant effects on 
disease expression. In other words, not only do the factors of biofilm, host response, and 
environment pose a risk, but the interactions between the factors can silence and/or enhance gene 
expression and the inflammatory response. Clinical and in vitro data have shown these epigenetic 
changes are associated with the host immune response and periodontal disease progression. For 
example, changes in methylation patterns have been closely associated with changes in the T cell 
and inflammatory response to periodontal pathogens (Alvarez C, et al., 2018). Other epigenetic 
changes identified in periodontal disease include altered methylation levels of the genes involved 
in the expression of inflammatory cytokines, including tumor necrosis factor-alpha (TNF- α), 
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interleukin-1-alpha (IL-1α), and IL-6. Figure 1.3.1 below, provided by Barros, S., et al., 2018, 
demonstrates the epigenetic influence in the periodontal environment. Various cell types 
involved with the inflammatory process are depicted. The figure highlights the influence of DNA 
methylation on the genes and proteins associated with the inflammatory process in periodontitis. 
The genes affected by the changes in methylation levels are listed and include IL-6, interleukin-8 
(IL-8), cyclo-oxygenase-2 (COX-2), and more (Barros, S., et al., 2018). 
 
Figure 1.3.1: Epigenetic effects of periodontal pathogens. Figure illustrates different cell types 
of the periodontium (fibroblasts, endothelial cells, and epithelial cells) as well as periodontal 
bacteria. In response to bacteria and inflammatory stressors, methylation is initiated at CpG-
regions of the cells. The genes affected are those involved with the inflammatory process. 
Hyperpermethylation of specific genes will lead to down-regulation of anti-inflammatory 
proteins, and hypomethylation of other genes will lead to up-regulation of pro-inflammatory 
proteins. 
 
 Specific bacteria have been identified to be closely associated with periodontal disease 
and lead to the increased immune host response and tissue destruction. The bacteria most 
associated and destructive to periodontal disease are Poryphromonas Gingivalis, Tannerella 
forsythia, and Treponema denticola. These bacteria are grouped into what is known as the “red 
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complex” because their presence indicates a high chance of having severe periodontal disease 
(Socransky SS, et al. 1998). Other bacteria have been identified to playing a role in periodontal 
disease and are categorized into other groups (orange, yellow, green); their presence is not as 
pathognomonic or pathogenic as the red complex. The presence of the pathogens in the 
periodontium induce several changes in the host as a defense mechanism. For example, the 
encounter of a periodontal pathogen with a host periodontal cell will trigger a chemical reaction 
from the host cell which leads to production of inflammatory mediators and pro-inflammatory 
cytokines. Although initiated as a defense mechanism, the chronic presence of these 
inflammatory molecules is ultimately what results in destruction of the periodontal tissues.  
 P.gingivalis is the predominant bacteria in chronic periodontitis and possesses several 
virulence factors, including proteases and lipopolysaccharides (LPS), which strengthen its role as 
a periodontal pathogen (Travis J, et al., 1997). One distinguishing virulence factor of P.gingivalis 
is its fimbriae. These filamentous surface appendages allow the bacteria to interact with the 
encountered gingival epithelial cells and disrupt the proposed barrier allowing for bacterial 
invasion into the host tissues (Socransky SS, et al. 1998). Between the risk factors, bacteria, and 
host response there exists an abundance of variability in disease expression which can 
additionally be influenced by genetic and epigenetic variables. Epigenetic components can 
selectively activate or inhibit specific genes and proteins therefore altering immune response. If 
the epigenetic change induced is hypomethylation, for example, this can lead to overexpression 
of the inflammatory mediators involved in periodontitis. Inflammatory mediators highly 
associated with periodontitis include interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), 
and interleukin-1-beta (IL-1β).  Although many studies have linked P.gingivalis with 
periodontitis, several studies have also found no association. This suggests that bacteria alone 
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may not be the sole cause of periodontitis, but rather the genetic-bacterial interactions and 
environmental influence on host response play a role in the phenotype and genotype of 
periodontal disease (Tomita S., et al., 2013).   
 The initial encounter of periodontal bacteria and host cells occurs at the epithelial barrier. 
The penetration of bacteria into the connective tissue is not only key to progression into 
periodontitis, but has also been connected to play a role in oncogenesis (Barros SP., et al., 2020). 
At the forefront of the bacteria are the epithelial cells working with their junctional proteins to 
maintain barrier function and the periodontal bacteria can alter and disrupt these cell-cell 
interactions. Chronic periodontal inflammation and biofilm bacteria can lead to DNA 
methylation modification of the genes involved with inflammation, bone metabolism, and 
epithelial function. In regards to epithelial barrier function, these epigenetic changes can reduce 
expression of the genes required for cell-cell adhesion and thus decrease the defense against 
pathogenic microbes. The function of the epithelial barrier can be evaluated by testing the 
transepithelial electrical resistance (TEER) in different scenarios (Barros SP., et al., 2020). In the 
Barros et al. studies, the authors demonstrated that upon infection with P.gingivalis, the 
epithelial barrier was compromised due to epigenetic influences on tight junctional proteins. 
Specifically, they found increased methylation levels on the genes coding barrier function which 
led to downregulation of the epithelial barrier proteins. Through TEER, they demonstrated that 
epigenetic changes on epithelial cell proteins resulted in decreased barrier resistance.  
 Epithelial barrier function is vital in other systems besides the oral cavity. So when 
discussing epigenetic effects on gingival epithelial barrier, it is prudent to consider the 
possibilities of these epigenetic effects on other epithelial barriers within the body. Several 
studies have linked periodontal diseases to other systemic conditions such as diabetes (Reynolds 
 
10 
M.A., 2014). Another mechanism accounting for this linkage, therefore, could be the local 
epigenetic changes within the periodontium. The altered methylation levels of inflammatory 
markers may be the link between periodontitis and systemic diseases. Considering the reverse, 
therapeutic strategies targeting epigenetic changes in periodontal disease may also reduce the 
risk of the systemic inflammation and associated diseases. It is through these connections that 
Barros et al., discussed how the modifications induced at the gingival epithelial barrier can also 
increase risk of systemic cancer development.  
 Epigenetic research has also progressed in regards to cancer development. DNA 
methylation is the best studied epigenetic alteration and has made many advances towards cancer 
research. As mentioned previously, hypermethylation usually leads to gene silencing. During 
oncogenesis, there are local sites of hypermethylation of tumor-suppressor genes which lead to 
tumor progression (Breivik and Gaudernack, 1999). The harsh environment created by 
pathogenic microbes has also been proposed to promote a tumor-favorable environment through 
epigenetic influences (Kusama K., et. al., 2016). The interaction between periodontal pathogens 
and the cells of the periodontium initiates an inflammatory cascade which involves cytokines 
that are also involved with oncogenesis. Several inflammatory cytokines have been linked to the 
development of cancer, such as nuclear factor-kappa-B (NF-ƙB). NF-ƙB is a pro-inflammatory 
mediator involved in several cancer types, including those related to the oral cavity. In the 
presence of inflammation, transcription for expression of this mediator will increase so the 
mediator changes to its active form. When the protein is inactive it remains in the nucleus, but 
when the protein is active it translocates to the nucleus of the cell which can then increase 
expression of genes involved in cell migration, cell proliferation, and apoptosis (Zhang P., et. al., 
2011). The progression and inflammation induced in periodontitis can theoretically have a 
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significant effect systemically, as epigenetic stressors can pose a systemic threat to the host from 
the local inflammatory changes. 
1.4 Epithelial Barrier Function 
 The hallmark and progression of periodontitis begins at the epithelial barrier. Gingival 
epithelial cells serve as a critical first line of defense against periodontal bacteria. The adhesion 
between cells is maintained by several types of junctions including desmosomal, adherens, and 
tight junctions.  The adhesion of these cells work to provide a physical barrier. The cells also 
serve as a chemical barrier by release of cytokines and chemokines. When encountered with a 
pathogen, the cells release these chemicals which trigger an immune response. The cytokines and 
chemokines increase inflammation to protect the body and fight off the pathogen, however, it is 
the presence of a continuous inflammatory response which ultimately what leads to chronic 
infection and destruction of tissue.  
 The interaction between periodontal pathogens and host cells at the epithelial barrier 
initiate the inflammatory response by activating expression of the pro-inflammatory cytokines or 
inhibiting expression of anti-inflammatory cytokines. Several pro-inflammatory mediators active 
in periodontal disease include interleukin‐6 (IL-6), interleukin‐8 (IL-8), and tumor necrosis 
factor‐alpha (TNF-α) (Jing Y, et. al., 2011). These mediators are not only key in induction of 
inflammation at the periodontium, but have also been connected to distinct roles in oncogenesis. 
Interleukin-8, for example, is also a pro-angiogenic cytokine involved in oral squamous cell 
carcinoma angiogenesis (Barros SP., et. al., 2020). The interactions between periodontal 
pathogens and host cells at the epithelial barrier, therefore, have the ability to induce periodontal 
inflammation as well as the potential to initiate progression of head and neck cancers.  
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 With the significant threat periodontal pathogens can hold, maintaining the adherence of 
epithelial cell barrier is crucial to limiting its permeability. The epithelial barrier works 
chemically to recognize microbial and viral invasions by initiating the inflammatory response 
when threatened in order to protect the deeper tissues (Peyyala R., et. al., 2012).  The primary 
structures providing adhesion of cells are part of the epithelial junction complex which is 
comprised of tight junctions, adherens junctions, desmosomes, and gap junctions. Tight junctions 
have been largely studied and act as semi-permeable gates. These mainly consist of the proteins 
occludens, claudins, and zonula occludens. Adherens junctions help regulate the activity and 
organization of the cell adhesion. Classic cadherins, like E-Cadherin, are the main proteins 
associated with these junctions (Takeichi M., 2014). Gap junctions work in maintaining 
homeostasis, regeneration, and development of the barrier (Takahashi, N., et. al., 2019). Finally, 
the desmosomes are specialized structures providing cell-to-cell contact which additionally 
regulate the activity of the junction (Groeger, S. E., & Meyle, J. 2015). Plakophilin-2 (PKP-2) is 
the main protein of the desmosome complex. Together, all the proteins and junctions work to 
prevent periodontal disease by physically preventing penetration of exogenous substances and 
chemically by initiating a pro-inflammatory response.  
1.5 TJP-1 
 The gingival epithelium consists of stratified squamous tissue which acts to protect the 
underlying tissues from the external environment. The integrity of the epithelial barrier is crucial 
to preventing infection by preventing the penetration bacteria into deeper tissues of the 
periodontium (Dale BA, 2002). The physical and chemical properties of the epithelial barrier 
serve as innate immune protection. These properties are especially important in the presence of 
the predominant periodontal pathogen, P.gingivalis, because of its unique virulence factor of 
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possessing fimbriae. The fimbriae threaten the barrier by binding with the epithelial cell adhesion 
molecules and consequently disrupting the integrity of the barrier (Amano A., 2007). Once the 
integrity of the epithelial cell barrier is compromised, the resistance against bacteria and other 
harmful substances decreases. The increased permeability of the barrier allows foreign 
substances to then penetrate the barrier more easily and invade the connective tissue. 
 The properties of epithelial cell adhesion are mediated by a number of cell-cell junctions 
which link the cells to function and communicate together. The role of cell-cell junctions is 
found in other systemic structures besides the oral cavity, such as in the intestines (Helander HF., 
2014). The epithelial cells in the periodontium are organized into several layers to help increase 
the strength of the barrier against a harsh environment like the oral cavity. Increasing the 
integrity, the tight junctions are one of the most essential junctions involved in providing the 
function and resistance of the epithelial barrier.  
 The tight junction is one of the components which aids in the adherence of the cells and 
diffusion of ions and molecules between cells (Zhini C., et al., 2016). These intercellular 
adhesion complexes serve as selective gates, making the epithelial barrier semi-permeable. The 
tight junctions also allow the cells to communicate via intercellular signaling. The tight junctions 
therefore also help with transmission of information between cells so the barrier functions in 
union. The tight junction is composed of two transmembrane proteins (claudin and occludin) and 
adaptor proteins (zonula occludens 1 and 2, also known as tight junction proteins 1 and 2) 
(Garcia MA., 2018).  
 Bacteria have also been shown to disrupt the barrier permeability epigenetically. Barros 
et. al., 2020, demonstrated an epigenetic influence to barrier permeability when they exposed 
cells to non-nucleoside DNMT-inhibitors. In this study, the authors assessed the barrier integrity 
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by measuring resistance through a method known as transepithelial electrical resistance (TEER). 
In presence of bacteria, the resistance of the barrier decreased rapidly but then increased when 
the epithelial cells were pre-treated with DNMT-inhibitors (Barros et. al., 2020).  Additionally, 
they linked the reduced function of the barrier to be a result of epigenetics by measuring the 
methylation levels on the proteins encoding the cell-cell junctions, including tight junction 
protein-1 (TJP-1).  Not only was an increased level of methylation found to decrease expression 
of TJP-1, but introducing DNMT-inhibitors prevented the amount of DNA methylation induced. 
This study was critical to discussing the role epigenetics plays in periodontitis because it 
demonstrated that red complex bacteria increase methylation levels of the epithelial barrier and 
that inhibiting the methylation enzymes (with DNMT inhibitors) can reduce the epigenetic 
effects induced by the pathogenic bacteria. 
1.6 DNMT Inhibitors  
 Epigenetic changes are transient and can be altered by different types of pharmacologics. 
To investigate potential therapeutic strategies, several categories of DNMT inhibitors have been 
identified based on their mechanism. Two main classes of DNMT inhibitors exist and are 
classified into nucleoside and non-nucleoside analogs. 
 Nucleoside analogs interfere after incorporation into damaged DNA. They are known to 
covalently trap DNMT-1 by incorporating it into DNA. These are considered the more effective 
inhibitors and consist of azanucleosides. In regards to tumorigenesis, these compounds were 
found to induce DNA hypomethylation and thus reactivate silenced tumor suppressor genes in 
malignant cells (Stresemann, C., et al., 2006).  
 Non-nucleoside DNMT inhibitors, on the other hand, interfere with the enzymatic 
activity of DNMT’s without directly incorporating them into the DNA. These inhibitors induce 
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changes during early development and remain active throughout life (Jones P., 2012). Molecules 
in natural substances such as curcumin, EGCG, and resveratrol have been shown to act as non-
nucleoside DNMT inhibitors (Fang MZ, et al., 2003). The impact of this introduces the potential 
to use natural substances as therapeutic strategies in fighting and preventing diseases. Curcumin, 
for example, has been found to induce about 15-20% decrease in DNA methylation levels as 
compared to other DNMT inhibitor agents (Liu, Z., et al., 2009). Considering the increasing 
evidence that these natural compounds serve as potent hypomethylation agents, more studies are 
also investigating and increasing the evidence on the specific effects of natural DNMT inhibitors 
against periodontal disease.  
1.7 EGCG 
 The consumption of green tea (Camellia sinensis) has long been associated with several 
health benefits including cancer prevention, anti-aging, and strong antioxidant activity (Singh 
B.N., et al., 2011). The major effect of green tea is associated to its polyphenols known as 
catechins, the most significant being EGCG (Epigallocatechin-3-gallate) (Khan N., et al., 2006). 
Many mechanisms have been found to explain the anti-inflammatory, carcinogenic, and 
antioxidant properties of EGCG. One of these mechanisms includes its epigenetic influence on 
methylation. Methylation induced by bacteria influences the expression of key inflammatory 
mediators, and the chronic presence of inflammation is the key factor which results in 
destruction of tissue in periodontal diseases. Cai Y., et. al. conducted a study in mice treated with 
P.gingivalis and EGCG. The authors found that when the periodontal tissues were exposed to 
EGCG, the levels of inflammation decreased which concluded that EGCG helps alleviate the 
destructive effects induced by P.gingivalis (Cai Y, et al., 2015).  
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 EGCG has also been demonstrated to act as a non-nucleoside DNMT-inhibitor. EGCG 
suppresses the DNMT enzymes by inducing and maintaining patterns without affecting the DNA 
sequence. It is a popular epigenetic inhibitor to study because it is not known to cause 
genotoxicity or cytotoxicity of cells, making it easy to work with and possessing a high safety 
profile with no serious risk. According to Wong C.P., et al., these authors demonstrated that 
EGCG inhibits DNMT activity, causes demethylation, and can reactivate methylation-silenced 
genes (Wong C.P., et al., 2011). The authors found that EGCG binds well to a pocket within the 
DNMT molecular structure. Looking at four specific genes which are methylation-silenced in 
esophageal cancers, these authors also found that after forty-eight hours of activity EGCG de-
methylated and reactivated all the genes studied by inhibiting the actions of DNMT. 
1.8 Resveratrol  
 Resveratrol (3,4’5-trihydroxystilbene) is another natural polyphenol produced by plants 
which possesses several antioxidant effects. Resveratrol is a polyphenolic phytoalexin which has 
been shown to exert anti-oxidant, anti-inflammatory, anti-cancerous, and cardio-protective 
properties. It can be found in berries, grapes, peanuts, and red wine. Polyphenols from different 
sources of food and herbs are attractive because they serve as a natural method to prevent 
inflammatory diseases in the diet (Willett, W. C. 1994). Growing attraction, the biologic effects 
of resveratrol have shown to decrease the pathogenesis of diabetes, rheumatoid arthritis, and 
neural degeneration.  
 Resveratrol, like EGCG, has also been shown to act as a non-nucleoside DNMT inhibitor. 
It can decrease DNMT expression and help reactivate silenced tumor suppressor genes. 
Abnormal methylation is known to play a key role in cancer development because it can lead to 
silencing of tumor suppressor genes. Natural products started receiving increasing attention as 
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pharmacotherapeutic and cancer-preventing agents. Like EGCG, resveratrol is one of these 
natural products that has gained increasing attention in cancer research. Several studies have 
evaluated the effects of EGCG, resveratrol, and curcumin to discover they can alter the 
methylation levels in cancer cells as well as increase gene expression (Mirza S, et al., 2013).  
 The specific mechanisms by which resveratrol reduces inflammation continue to be 
evaluated. Several studies have found different mechanisms to explain this. For example, 
resveratrol administration has been shown to suppress NF-ƙB signaling and inhibit the loss of 
alveolar bone via reduced interleukin-17 (IL-17) expression in gingival tissues (Casati, M. Z., et 
al., 2013). Inhibiting the NF-ƙB signal leads to reduction of the toll-like receptor-4 (TLR-4) 
induced inflammatory response, an important receptor for lipopolysaccharide (LPS) released by 
periodontal pathogenic bacteria. Resveratrol has additionally been shown to decrease periodontal 
breakdown and modulate local levels of cytokines in rats with periodontitis (Minagawa T, et al., 
2014). Minagawa 2014 found that a relatively low-dose of resveratrol (8-15 uM) suppressed the 
expression of IL-8 by epithelial cells against P.gingivalis. In the rat model study by Casati et al., 
2013, resveratrol was also found to minimize the alveolar bone loss seen in periodontal disease 
via its inhibitory role on interleukin-17 (IL-17) and reduction in IL-1β (Casati et al., 2013). T-
helper 17 (Th-17) cells are a major source of IL-17, which stimulate production of 
osteoclastogenesis-related factors like IL-8. IL-8 is a significant interleukin because it also 
induces chemotaxis and phagocytosis in neutrophils. In another study, resveratrol was found to 
help prevent alveolar bone loss on rats with periodontitis. The authors found that resveratrol has 
suppressed inflammatory marks of MMP-2, MMP-9, and COX-2 in a ligature LPS model 
(Bhattarai, G.,et al., 2016).  This study is significant because it introduced resveratrol as an 
inhibitor of inflammatory markers significant to periodontal disease.  
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 Although several studies have demonstrated resveratrol therapeutic agent against 































CHAPTER 2: DNA-Methyltransferase Inhibitors Effect on Epithelial Barrier Function 
 
2.1 INTRODUCTION 
 Periodontal disease is characterized by chronic inflammation of the tissues supporting the 
dentition: the gingiva, periodontal ligament, and bone. It is considered one of the most common 
infections and estimated to affect 20-50% of the world population, with severe forms affecting 
approximately 10% of adults (Sanz M., 2010).  Bacteria, environment, lifestyle, genetics, and 
epigenetics are the most common factors found to increase risk of developing periodontitis.  
 Epigenetics consists of changes in gene expression which are not encoded in the DNA 
sequence. Epigenetic influences consist of external factors such as smoking, diet, bacteria, and 
age (Barros S.P & Offenbacher S, 2014). These epigenetic markers lead to chemical alterations 
of DNA and its associated proteins which result in the remodeling of chromatin and affecting 
activation or inactivation of a gene (Bird A., 2002). Unlike our genome which is set, the 
epigenome is a constant dynamic influence which changes continuously throughout an 
organism’s life.  
 Periodontitis is expressed differently across individuals in terms of severity, progression, 
and extent. The host response to inflammation varies across individuals and accounts for the 
varying susceptibility of disease. The gingival epithelial cells are the first line of defense against 
pathogenic bacteria and their exposure initiates the start of the inflammatory response. It is at this 
interface that bacteria initiate the inflammatory response and induce epigenetic modifications of 
the host cells. The epithelium acts like a chemical and physical barrier against bacteria helping 
prevent penetration of pathogens deeper into the connective tissues. This physical barrier is 
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maintained by tight junctions, adherent junctions, gap junctions, and desmosomes. The tight 
junction protein-1 (TJP-1) is widely used as a marker of tight junction and its upregulation has 
been shown to promote tumor development in several types of cancer (Li, M., et al., 2020). 
Down-regulation of the genes for TJP-1 leads to disruption of the integrity of the epithelial 
barrier. In multiple myeloma patients, mRNA expression of TJP-1 was negatively correlated 
with methylation levels (Li, M., et. al., 2020). These studies in turn demonstrate the significant 
impact epigenetic modifications can cause by altering TJP-1 expression.  
 P.gingivalis is one of the bacteria known to be most associated with development of 
periodontitis. S. Socransky described its role as a virulent pathogen and categorized it as a ‘red 
complex’ along with other bacteria, F. nucleatum and T. forsythia (Socranksy SS., et al., 1998). 
The red complex bacteria signify the bacteria most virulent and pathognomonic to periodontitis. 
What is important to still consider though, is that periodontitis is a multifactorial disease and 
other factors account for the severity and variability in disease expression. Evidence gathered 
upon the interactions between the gene-environment has come to show that it is actually the 
host’s variation which ultimately influences the disease phenotype (Barros & Offenbacher 2008). 
With growing evidence of these interactions, epigenetics is starting to be identified as one of the 
most significant factors of disease expression. 
 DNA methylation and histone deacetylation are the two most common epigenetic 
modification mechanisms (Shaw R., 2006).  Currently, methylation is the best understood 
modification and most commonly leads to gene silencing. Methylation involves insertion of 
methyl groups into cytosine residues of DNA at the promoter region. DNA methyltransferases 
(DNMT’s) are the enzymes which insert the methyl groups to the C5 position of the cytosine 
ring of DNA and are responsible for maintaining these patterns through replication (Wu CT., et 
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al., 2001).  The addition of these methyl groups alters the natural shape of DNA which 
consequently prevents the binding of enzymes required in the transcription and translation of 
genes. 
 Chronic periodontal inflammation can lead to DNA methylation and DNA methylation 
can lead to chronic inflammation. Periodontal pathogens initiate an inflammatory response 
through its interactions with the encountered cells in the periodontium. The gingival epithelial 
cells form a chemical and physical barrier to protect the deeper tissues against pathogens, and it 
is at this interface that marks the progression and initiation of periodontal disease. When 
encountered with bacteria, the cells initiate a series of chemical changes which lead to 
production of cytokines and inflammatory mediators. The bacteria induce epigenetic changes to 
the epithelial cells which reduce the integrity of their physical barrier and they are then able to 
penetrate the deeper tissues more easily. This leads to a continued and chronic inflammatory 
response which leads to further and uncontrolled tissue destruction.  
 Therapeutic strategies have been developed to help reduce the epigenetic influences by 
inhibiting the effects of the DNMT’s. Increasing interest and significance, natural compounds are 
the target of attention and have been shown to help against cancers and diseases. 
Epigallocatechin-3-gallate (EGCG), a popular substance colloquially known as ‘green tea,’ has 
evidence illustrating its anti-oxidant, anti-inflammatory, and anti-carcinogenic properties. 
Recently, EGCG has also been proven to have hypomethylation effects acting as a DNMT 
inhibitor, and serving as a protective factor. In regards to periodontal disease, EGCG has been 
shown to downplay the methylation levels induced by periodontal bacteria on barrier proteins 
tight junction protein-1 (TJP-1) and Plakophilin-2 (PKP2) (Barros, S. P., et. al., 2020). Other 
natural substances growing data illustrating its protective epigenetic effects in the body include 
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curcumin, RG-108, and resveratrol. Unlike curcumin and RG-108, however, there is no current 
data demonstrating resveratrol as a protective factor against periodontal disease.  
 In this study, we aim to investigate the epigenetic influence of resveratrol against 
periodontal bacteria. Understanding the role of EGCG as a DNMT inhibitor in periodontal 
disease, we are interested in investigating the effects of resveratrol in comparison to EGCG. We 
will first target the cytotoxicity of resveratrol to find a working concentration. Once the safe 
concentration level of resveratrol is found, we will evaluate the changes in methylation levels 
and gene expression of TJP-1. Our goal is to study the potential effects of resveratrol as a DNMT 
















1. To investigate the potential effects of resveratrol as a natural DNA-Methyltransferase 
(DNMT) inhibitor on epithelial barrier function in response to infection with periodontal 
pathogens in human gingival epithelial cells. 
 
2. To determine how gene expression and methylation status of Tight Junction Protein-1 
(TJP-1) is modified in human gingival epithelial (HGEp) cells after infection with 
P.gingivalis.  
 
3. To determine whether pre-treatment with resveratrol can interfere with the methylation 
status and expression levels of TJP1 in HGEp cells infected with P.gingivalis in 














 It is hypothesized that infection of HGEp cells with periodontal pathogen, P.gingivalis, is 
able to induce epigenetic changes that can alter the epithelial barrier function, and these changes 


















2.4 MATERIALS & METHODS 
2.4.1 Cell & Bacterial culture 
 Human gingival epithelial cells (HGEp) were purchased from CellnTec and maintained 
according to the manufacturer’s instructions. All cultures would be maintained in a 5% CO2, 100% 
humidity, 37◦C incubator and used between passages 3 and 6. Porphyromonas Gingivalis A7436 
was cultured anaerobically at 37◦C in Wilkins-Chalgren anaerobe broth medium (Thermo 
Scientific) for 3-4 days. Cell number will be measured via the optical density. When the optical 
density reaches 0.5, the concentration of P.gingivalis is equal to 10 9
 
CFU/ml.  
2.4.2 DNMT Inhibitors 
 Resveratrol and EGCG were obtained from Sigma-Aldrich (St. Louis, MO) and dissolved 
in DMSO. To test the effects of the inhibitors on infected cells, DNMT inhibitors were added 24 
hours before the addition of P.gingivalis.  
2.4.3 Cell Viability 
 Human gingival epithelial cells (HGEp) were plated in 96-well plates at densities of 50,000 
cells/well. The cells were incubated at 37 °C and 5 % CO2 to allow for the cells to attach. After 
24 hours incubation, the cell culture medium was replaced by prepared CnT-PR culture medium 
containing different concentrations of resveratrol and Green tea catechin, epigallocatechin-3-
gallate (EGCG) (1, 5, 10, 50, and 100 μM) for another 24 hours incubation.. To analyze 
cytotoxicity of each DNMT inhibitor, cells were incubated after adding 500 μl of 1X presto blue 
reagent for 20 mins at 37 °C, 5 % CO2. Then, the fluorescence intensity of the Prestoblue reagents 
were measured using a fluorescence microplate reader (excitation ~560 nm, emission ~590 nm).  
2.4.4 Transepithelial Electrical Resistance (TEER) 
 HGEp cells were seeded in 12-mm transwells with 0.4μm pore-size Pore Polyester 
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Membrane Inserts (Costar) and cultured for 24 hours. The cells oriented with the basal side toward 
the insert membrane surface. To test the effect of infection, cells were exposed to P.gingivalis (50 
MOI). The optimum bacterial concentration for cell viability was provided by the lab from 
previous experiments. To test the effects of the DNMT inhibitors on non-infected and infected 
cells, either resveratrol (5 μM) or ECGC (10 μM) were added. Transepithelial electrical resistance 
(TEER) was measured using EVOM2 Epithelial Voltammeter (World Precision Instruments, FL) 
at different time intervals: 0, 2, 4, 6, 18, and 24 hours. Background resistance from cell-free 
membranes in culture medium was subtracted from initial resistance values. 
2.4.5 RNA Isolation and Quantitative Real-Time PCR  
 RNA was isolated from HGEp cells using the AllPrep DNA/RNA Mini Kit (Qiagen, 
Valencia, CA). RNA was quantified using NanoDrop (Thermo Scientific, Wilmington, DE). For 
each sample, 300ng of RNA was used to generate complementary DNA (cDNA) through reverse 
transcription reactions using the SuperScript VILO cDNA Synthesis Kit (Invitrogen TM, Life 
Technologies TM, Grand Island, NY). Quantitative real-time PCR (qPCR) was performed using 2 
μL of cDNA, 7.5 μL of Taqman Universal PCR Master Mix, 0.75 μL of Taqman Gene Expression 
assay Mix with primers for TJP1 and 5.5 μL of ddH20. Reactions were done in a 7000 Sequence 
Detection System (ABI Prism, Applied Biosystems, Carlsbad, CA). 
2.4.6 Quantification of DNA methylation at specific sites 
 Genomic DNA was isolated from HGEp cells using the All-Prep DNA/RNA Mini Kit 
(Qiagen, Valencia, CA). DNA was quantified using NanoDrop (ThermoScientific, Wilmington, 
DE). Genomic DNA (500 ng) was aliquoted into four equal portions for different reactions using 
EpiTect Methyl II DNA Restriction Kit (Qiagen Cat# 335452): Mock digest (no digestion), 
methylation-sensitive digest (digestion of unmethylated and partially methylated DNA only), 
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methylation-dependent digest (digestion of methylated DNA only), and double digest (digestion 
of both methylated and unmethylated DNA). DNA digests were performed according to the 
manufacturer’s instructions. Digested DNA was then quantified by qPCR using EpiTect Methyl II 
PCR Primer Assay (Qiagen) for human TJP-1 (CgP Island 104402, Cat# EPHS104402-1A). With 
a 7000 Sequence Detection system (ABI Prism, Applied Biosystems, Carlsbad, CA), qPCR was 
performed using 12.5 μL of RT SYBR Green qPCR Master Mix, 1 μL of PCR primer mix for the 















2.5 RESULTS  
2.5.1 Cytotoxicity  
 To determine if DNA methylation was involved in the effects of P.gingivalis on gingival 
epithelial cells, resveratrol was tested. EGCG was used as a positive control for DNMT inhibition. 
DNMT inhibitors exhibit cytotoxicity so it was important to perform a dose-response analysis on 
its effects on HGEp cells. Cellular viability needed to be assessed in order to determine 
experimental optimization of health in the presence of DNMT inhibitor exposure. The figures 
below illustrate the results of HGEp exposure to a range of concentrations of resveratrol and EGCG 
for an optimal cell viability near 80%. Error bars illustrate standard deviation from 3 consequent 
repeated samples of each DNMT inhibitor concentration. From this analysis, 5 μM of resveratrol 
and 10 μM EGCG were selected for non-toxic concentrations for our experiments. EGCG 
concentration of 10 µM selected due to previous experiments in lab using same concentration. 
EGCG concentrations with HGEp cells had wider range of standard error. The figures below 
illustrate the inhibitor concentrations which were selected for use in the subsequence experiments: 




Figure 2.5.1 HGEp cell viability following treatment with various DNMT inhibitor (resveratrol) 
concentration to determine cytotoxicity. Error bars represent standard deviation across multiple 
samples. Arrow illustrates selected concentration of resveratrol for experiments. Resveratrol 

























Figure 2.5.2 HGEp viability following treatment with various DNMT inhibitor (EGCG) 
concentration to determine cytotoxicity. Error bars represent standard deviation across multiple 
samples. Arrow illustrates selected concentration of EGCG for experiments. EGCG concentration 
































 TEER is a widely accepted quantitative technique to measure the integrity of tight junction 
dynamics in cell culture models of epithelial monolayers. It assesses the permeability of epithelial 
cells cultured on a transwell insert by measuring the resistance across the cell monolayer with 
electrodes placed within the transwell and outside the transwell. Figure 2.5.3 illustrates 
transepithelial electrical resistance (TEER) of 1-non-infected human gingival epithelial cells 
(nHGEp), 2- 24h after bacterial (P.gingivalis) infection (iHGEp), and 3- HGEp pre-treated with 5 
µM Resveratrol and 10 µM EGCG for 24h before infection. TEER results of pre-treated HGEp 
cells were analyzed after 24h after infection with P.gingivalis. TEER analysis illustrates that 
infected epithelial cells pre-treated with resveratrol had increased epithelial resistance compared 
to non-infected cells and infected cells exposed to EGCG. The increased barrier resistance of 
infected cells pre-treated with resveratrol is not as strong as non-infected cells, but is comparable 
to infected cells pre-treated with EGCG. Although the barrier resistance is not as high as non-
infected cells, the increased barrier resistance seen when infected cells were pre-treated with 
DNMT inhibitors is statistically significant (p < 0.05) compared to infected cells. This data 
indicates that epigenetic changes induced by bacteria contribute to pathogen-induced decrease in 
epithelial barrier function, and the addition of natural DNMT inhibitor compounds can serve as a 






Figure 2.5.3 TEER readings in (Ohms) testing barrier resistance of non-infected HGEp cells 
(nHGEp), infected HGEp cells with P.gingivalis (iHGEp), infected HGEp cells pre-treated with 
resveratrol, and infected HGEp cells pre-treated with EGCG. Error bars represent standard 
deviation of repeated sample readings. Stars over error bars indicate statistically significant 
differences (p < 0.05). Infected cells pre-treated with 5 µM resveratrol had increased barrier 






2.5.3 qPCR Analysis 
 Epigenetic changes can alter methylation levels in cell adhesion genes leading to altered 
cell adhesion protein expression levels. Analysis of RNA of tight junction protein (TJP-1) with 
qPCR demonstrates increased mRNA levels of TJP-1 in cells pre-treated with resveratrol and 
EGCG. When DNMT inhibitors, resveratrol and EGCG, are introduced into the infected epithelial 
cells, the expression of TJP-1 increases to a similar level of non-infected cells. The increased levels 
of TJP-1 correlate with the increased level or barrier resistance observed from TEER results. 
Although mRNA levels of TJP-1 were increased in the presence of DNMT inhibitor resveratrol, 
the levels are less in comparison to infected cells pre-treated with EGCG and non-infected cells. 
Despite the reduced amount compared to its controls, resveratrol influenced and increased mRNA 
levels of TJP-1. The amount of mRNA changes seen when infected cells were treated with both 
DNMT inhibitors is statistically significant compared to infected cells. The data indicate 
resveratrol serves as an effective epigenetic compound to improve epithelial barrier function in 





Figure 2.5.4 Relative mRNA levels of Tight Junction Protein (TJP-1) of non-infected human 
gingival epithelial cells (nHGEp), infected gingival epithelial cells with P.gingivalis (iHGEp), 
infected cells pre-treated with resveratrol, and infected cells pre-treated with EGCG. Error bars 
dictate standard error. Stars indicate statistical significance (p < 0.05). Infected cells pre-treated 
with 5 µM resveratrol had increased levels of mRNA changes compared to infected cells pre-







2.5.4 DNA Methylation 
 The specific epigenetic changes we evaluated are DNA methylation because of DNMT 
inhibitor compounds, resveratrol and EGCG. Pre-treatment of HGEp with DNMT inhibitors 
demonstrated altered levels of mRNA expression on tight junction protein-1 (TJP-1). Excessive 
methylation usually results in gene silencing, whereas hypomethylation can result in gene 
overexpression. Our results with TEER demonstrated modification of barrier function after HGEp 
cells were exposed to bacteria and DNMT inhibitors. To evaluate if these functional differences 
are epigenetically induced, DNA methylation levels of TJP-1 were quantified. Compared to non-
infected cells, cells infected with P.gingivalis (iHGEp) exhibited an increase in methylation on 
TJP-1. When the infected cells were pre-treated with resveratrol, there was a statistically 
significant decrease in the methylation levels similar to infected cells. This significant difference 
is similar to those infected cells pre-treated with EGCG. They hypomethylation corresponds with 
the overexpression of TJP-1 seen with qPCR analysis as well as the increased barrier resistance 
observed with TEER. These results suggest resveratrol to be an effective DNMT inhibitor on 






Figure 2.5.5. DNA-Methylation levels of Tight Junction Protein-1 (TJP-1) of non-infected human 
gingival epithelial cells (nHGEp), epithelial cells infected with P.gingivalis (iHGEp), infected 
epithelial cells pre-treated with resveratrol, and infected epithelial cells pre-treated with EGCG. 
Error bars indicate standard deviation. Stars indicate statistical significance (p < 0.05). Infected 
cells pre-treated with 5 µM resveratrol exhibited decrease methylation similar to non-infected cells 









 Periodontal disease is a chronic inflammatory disease involving the structures that 
support the teeth in the oral cavity. The risks for periodontal disease are multifactorial 
encompassing microbial, genetic, epigenetic, lifestyle, and environmental factors (Barros S.P. & 
Offenbacher S., 2009). The initiation of the inflammatory cascade begins at the gingival 
epithelial cell barrier. The adhesion of epithelial cells together protects against bacteria as a 
physical barrier, but also as a chemical barrier by initiating an inflammatory cascade. Bacteria 
interact with receptors at the epithelial interface which initiate a series of complex inflammatory 
and signaling pathways (Peyyala R., et. al., 2012). Bacteria begin to introduce epigenetic 
modifications which alter the inflammatory response and influence the amount of destruction 
caused by upregulated pro-inflammatory cytokines and inflammatory mediators. Evidence 
suggests epigenetics influence the upregulation of periodontal inflammatory markers including 
interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis factor-alpha (TNF-α), and nuclear 
factor-kappa-B (NF-kB) (Barros, S., et al., 2018). The primary epigenetic modifications consist 
of DNA methylation and histone modification.  
 DNA methylation is induced by DNA methyltransferases (DNMT’s) which serve to 
insert de novo methyl groups into the 5’-Cytosine-phospho-Guanosine-3’ (CpG) sites of DNA, 
as well as maintain the patterns during replication. Methylation of DNA most often leads to gene 
silencing, which can serve as a protective or dangerous factor. Methylation patterns have been 
studied extensively in the role of cancer. Studies have investigated the role of methylation on 
tumor suppressor genes and found that not only do they play a significant role in the upregulation 
of tumorigenesis, but have also investigate pharmacologic therapies working against the 
methylation to decrease the risk of progression of and combat these diseases (Barros SP., et al., 
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2020). Increasing influence exponentially is the role of DNMT inhibitors, which serve to 
decrease the DNMT function resulting in decreased methylation and upregulation of certain 
genes. Two common natural compounds shown to possess DNMT inhibitor function are 
epigallocatechin-3-gallate (EGCG) and resveratrol. Evidence exists to show EGCG plays a 
significant epigenetic role not only in systemic diseases, but also in periodontal diseases. When 
exposed to EGCG, Barros SP 2020 found an increase in the upregulation of gingival epithelial 
barrier function. The authors observed an effect of EGCG on barrier function proteins: tight 
junction protein-1 (TJP-1), plakophilin-2 (PKP-2), and cadherin-1 (CAD-1). These proteins are 
together responsible for barrier function and providing resistance against bacterial pathogen 
invasion. Periodontal pathogens have the capability to silence the expression of these barrier 
proteins via epigenetic modification of hypermethylation, consequentially leading to decreased 
integrity and increased permeability of the epithelial barrier.  
 In this study, we sought to evaluate the effect and potency of resveratrol as a DNMT 
inhibitor. Like EGCG, resveratrol is an attractive compound because of its natural antioxidant 
and anti-inflammatory properties. Previous studies have demonstrated the epigenetic role of 
EGCG on gingival epithelial cells and in this study we aimed to see if resveratrol can act in 
similar fashion. These natural compounds have cytotoxic capability and it is important to 
determine an optimum concentration for cell viability. Using PrestoBlue cell viability assay and 
checking optimal density, 5 uM of resveratrol was the selected concentration to investigate its 
epigenetic influence. Other studies that have worked with resveratrol have also worked near 
similar concentrations, and in our studies we obtained an average 80% cell viability at this 
concentration (Minagawa T., et. al., 2014). To evaluate effects on barrier function, TEER was 
used on non-infected, infected, and infected gingival epithelial cells pre-exposed to EGCG and 
 
39 
resveratrol. Cells were infected with P.gingivalis, the bacteria most frequently associated with 
severe periodontal disease (Rafei M., et al., 2017).  
 Our experiments with TEER demonstrated decreased barrier integrity in cells infected 
with P.gingivalis. After the infected cells were pre-treated with resveratrol and EGCG for 24 
hours, an increased barrier function was observed. To analyze the epigenetic modification on 
barrier function, qPCR analysis of gene expression and methylation level analysis was performed 
on the protein coding gene, TJP-1. When exposed solely to P.gingivalis, TJP-1 expression 
decreased and methylation levels increased demonstrating epigenetic influence of the bacteria.  
When these infected cells were pre-treated with resveratrol, however, a decreased level of 
methylation at site TJP-1 was observed in similar fashion to EGCG. Hypermethylation usually 
leads to gene silencing, and inhibiting the methylation induced with DNMT’s can reverse this 
effect. Consistently, we found statistically significant increased expression of TJP-1 in infected 
cells pre-treated with the DNMT inhibitors, EGCG and resveratrol. As a result, barrier resistance 
increased although the resistance was not as strong as non-infected cells. Our studies 
demonstrate resveratrol can serve as a powerful DNMT inhibitor like EGCG, which can improve 
the integrity of the epithelial barrier and protect the connective tissues in presence of bacterial 
infection.  
 Our studies indicate that resveratrol is effective in reducing the hypermethylation effect 
of P.gingivalis on TJP-1 and epigenetically improving barrier function in similar fashion to 
EGCG. Resveratrol, therefore, has the potential to reduce the risk and severity of periodontitis by 
acting at the fore-front of bacterial invasion. Increasing the integrity of the barrier can serve to 
limit the amount of bacterial penetration into the connective tissue and potentially reducing 
disease severity and systemic effects.  
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  A limitation of this study is the evaluation of barrier resistance as a mono-layer since 
clinically the bacteria encounter multiple layers of epithelial cells. Our data, however, supports 
additional studies to evaluate resveratrol as a potent DNMT inhibitor clinically on the multiple 
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